Advanced disease stage (T3/T4) also showed a trend suggesting an increased risk of post-TORS haemorrhage (22.36% versus 15.28%), but did not achieve significance in our analysis (RR = 1.48, 95% CI: 0.87–2.53).
2
—
—
The sentences
Advanced disease stage was associated with increased risk of post-TORS haemorrhage but failed to reach significance in our analysis RR = 1.48, 95% CI: 0.87–2.53; I 2 = 0%).